Total submissions: 18
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000039389 | SCV000051600 | benign | not specified | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000039389 | SCV000063073 | benign | not specified | 2012-04-16 | criteria provided, single submitter | clinical testing | Met179Thr in exon 7 of TMEM43: This variant is not expected to have clinical sig nificance because it has been identified in 29.7% (2082/47020) of European Ameri can chromosomes from a broad population by the NHLBI Exome Sequencing Project (h ttp://evs.gs.washington.edu/EVS/ dbSNP rs2340917). |
Eurofins Ntd Llc |
RCV000039389 | SCV000114144 | benign | not specified | 2013-03-12 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000039389 | SCV000153046 | benign | not specified | 2013-08-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000039389 | SCV000168991 | benign | not specified | 2011-08-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000039389 | SCV000314288 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV000244862 | SCV000317504 | benign | Cardiovascular phenotype | 2015-10-20 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000771044 | SCV000902545 | benign | Cardiomyopathy | 2018-03-15 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000987121 | SCV001136326 | benign | Arrhythmogenic right ventricular dysplasia 5 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000987121 | SCV001716417 | benign | Arrhythmogenic right ventricular dysplasia 5 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000987121 | SCV002098522 | benign | Arrhythmogenic right ventricular dysplasia 5 | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001838544 | SCV002098523 | benign | Emery-Dreifuss muscular dystrophy 7, autosomal dominant | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000039389 | SCV001739547 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000039389 | SCV001922764 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000039389 | SCV001927619 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000039389 | SCV001951653 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000039389 | SCV001976058 | benign | not specified | no assertion criteria provided | clinical testing | ||
Cohesion Phenomics | RCV000771044 | SCV003802995 | benign | Cardiomyopathy | 2022-09-23 | no assertion criteria provided | clinical testing |